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Objective: To review existing (CF) self-care research and explore the possibilities
of a more sociologically informed approach.
Method: A search of medical and social science research databases was undertaken
using the key words ‘cystic ﬁbrosis’ and ‘self-care’ (along with synonyms and
related concepts). Key texts were then compared and analysed thematically.
Results: Despite growing discomfort with traditional models of compliance, CF
research seldom explores alternative approaches to research and practice. Of
particular concern was the overwhelming emphasis upon quantitative outcome-
based studies and a concomitant lack of qualitative research on the process of
self-care, particularly among adults. The lack of signiﬁcance assigned to the social
and cultural conditions in which self-care is undertaken also needs to be addressed.
Starting with the methodological issue of representing patients in research and then
reviewing some relevant ﬁndings, an alternative sociological approach that helps
contextualise varieties of preferred styles of self-care is ﬁnally suggested.
Conclusion: While CF research has been slow in responding to changing ideo-
logical trends, traditional compliance models remain valuable tools for clinicians.
However, alternatives such as ‘concordance’ should also be considered where
appropriate. This review suggests a pluralistic approach is required which by paying
attention to how various identities are socially constructed and performed, will
enable clinicians to recognise a variety of distinct styles of self-care. These affect
possible outcomes rather than determine them and therefore provide a range of
frameworks for enabling a more sensitive engagement with patients.
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Self-report methods to assess adherence to medication have been widely used but
criticised as potentially overestimating adherence. This study assesses agreement
between objective adherence to nebulised therapy, measured by three months of data
downloaded from the i-neb (Phillips UK), and self-reported adherence in 78 patients.
Median objective adherence was 36%(IQR 5−84.5)of prescribed regimen, paired
t-test and associated conﬁdence interval(CI) gave assessment of mean upward bias
of self-report at 25.3 (18.7−31.9).
Data was split according to objective adherence. Paired t-test(CI)used to assess mean
bias of patient report for each group. For 33 subjects, objective adherence 0−25%,
mean bias was 42.4 (32.0−52.7). Fifteen participants, with 26−50% adherence,
demonstrated mean bias of 32.1 (20.3−44) using self report. Bias of self report
dropped to 17.5 (6.9−28.1) in eight patients with 51−75% adherence and was
minimal at 6.1 (0.6−11.6) in 13 participants with 76–100% adherence. Nine patients
reported 100% adherence with objective adherence of over 100%, mean bias
−13.9 (−21.5 to −6.26). These patients identiﬁed a prescription which matched
medical record suggesting this was not due to misunderstanding of prescription.
This data shows high tendency to to have greater upward bias in estimation where
objective adherence is low (0−25%). This tendency continues but decreases as
objective adherence improves and is minimal in people with objective adherence
of 76–100%. People with over 100% adherence to prescribed treatment have a
signiﬁcant and consistent tendency to underestimate adherence levels. Self reported
adherence does not provide accurate adherence data for each individual compared
to electronic monitoring.
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Adherence to treatment is inﬂuenced by many factors and is critical to optimal
Cystic Fibrosis (CF) management. Adherence to treatment plans in CF is reported
to occur less than 50% of the time. Psycho-social factors are beginning to emerge
as strong predictors of adherent behaviour. In addition, both severity of disease and
illness state (eg inpatient) may affect subjective responses to surveys.
Aim: To explore both personality and psychosocial factors and their impact on
adherence behaviour in patients with CF. To explore the impact of illness effect and
severity effect on adherence behaviour reporting.
Methodology: Demographic and health related measures were collected in addition
to a battery of self-administered and pharmacist administered questionnaires inves-
tigating personality (NEO-PI), psychosocial (depression, anxiety, social support,
locus of control, quality of life, health beliefs) and adherence behaviour (Morisky
score, pharmacy pick-up) were given to each patient requiring an inpatient ad-
mission for an exacerbation of their CF. All tests were re-administered 4 weeks
following their in-patient admission in a stable phase.
Results: The study recruited 12 participants. Results indicate that both illness and
severity of illness impact upon adherence behaviour reporting. The psychosocial
factors related to reported adherence were social support (p< 0.05), health beliefs
(p< 0.05), health related quality of life (p< 0.05), treatment burden (p< 0.05)
and social functioning (p< 0.05). Also ﬁnancial perception inﬂuenced adherence
reporting.
Conclusion: Adherence behaviour is complex, involves multiple factors and is
subject to speciﬁc biases. Further investigation into understanding the contribution
of psychosocial factors to adherence behaviour is important.
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Introduction: Adaptive Airway Delivery(AAD) devices are now routinely used in
many clinics for antibiotic inhalation therapy. Adherence is readily calculated but
is dependant upon the device being brought to clinic to be downloaded. The aim of
this study was to examine whether adherence differed in the months that patients
brought their AAD devices to clinic.
Methods: Chronic Pseudomonas growths are treated in our clinic with inhaled
colistin via an AAD device (I-neb, Respironics). All families are asked to bring
their device to each clinic. Using software provided by the manufacturers, data on
the device was downloaded and monthly adherence to inhalation therapy calculated
for each patient over a 2 year period. The frequency with which the device was
brought to clinic and treatment times were also documented.
Results: Adherence data for 16 children (age range 4−15 years) have been analysed.
Median(range) number of clinic attendances over this period was 11(range 9−14)
for each patient. The devices were brought to clinic approximately 50% of the time.
Mean adherence to inhaled treatment was signiﬁcantly higher in the months that the
AAD device was brought to clinic (Mean(SD), 79(24)%) compared to the months
where it was left at home (72(27)%; p< 0.001). Overall median treatment times of
5 minutes did not vary between the months it was downloaded and the months it
was not.
Conclusions: Adherence to inhaled therapy is better in the months that patients
bring their AAD devices to clinic. Whether this is because adherence improves in
anticipation of clinic or whether it improves following feedback at clinic is an area
for further investigation.
